Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial.

Research output: Contribution to journalArticle

Abstract

Four randomized studies show that adjuvant radiotherapy (RT) lowers the risk of subsequent ipsilateral breast events (IBEs) after breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) by approximately 50% after 10 to 15 years. We present 20 years of follow-up data for the SweDCIS trial.

Details

Authors
  • Fredrik Wärnberg
  • Hans Garmo
  • Stefan Emdin
  • Veronica Hedberg
  • Linda Adwall
  • Kerstin Sandelin
  • Anita Ringberg
  • Per Karlsson
  • Lars-Gunnar Arnesson
  • Harald Anderson
  • Karin Jirström
  • Lars Holmberg
Organisations
External organisations
  • Uppsala University
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)3613
JournalJournal of Clinical Oncology
Volume32
Issue number32
Publication statusPublished - 2014
Publication categoryResearch
Peer-reviewedYes

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Surgery Research Unit (013242220), Paediatrics (Lund) (013002000), Pathology, (Lund) (013030000), Cancer Epidemiology (013007100)